AZTR - Azitra Inc
IEX Last Trade
0.65
0.008 1.154%
Share volume: 146,590
Last Updated: Fri 30 Aug 2024 07:49:10 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.64
0.01
1.17%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-9.15%
1 Month
-16.23%
3 Months
-88.97%
6 Months
-91.88%
1 Year
-99.06%
2 Year
-99.56%
Key data
Stock price
$0.65
DAY RANGE
$0.64 - $0.67
52 WEEK RANGE
$0.49 - $68.40
52 WEEK CHANGE
-$0.99
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website:
Employees: 14
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website:
Employees: 14
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
azitra, inc. is a preclinical stage biotechnology company harnessing the power of the microbiome to treat skin disease. the company was founded in 2014 by scientists from yale university and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its programs in atopic dermatitis and targeted orphan indications. for more information visit www.azitrainc.com.
Recent news